Xiyuan Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Beijing China (1955)

Organization Overview

First Clinical Trial
2015
NCT02762136
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Director of Xiyuan Hospital | xi yuan hospital | xiyuan hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

yiqi (1 trial)

Drugs in Phase 2 Trials (5)

jianpi qinghua (1 trial)

mosapride (citrate) (1 trial)

omeprazole (prilosec) (1 trial)

qizhi weitong (1 trial)

xiang-sha-liu-jun (1 trial)

Drugs in Phase 1 Trials (1)

jiedu tongluo (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 1)

Depressive Disorder (Phase 1)

Dyspepsia (Phase 2)

Gastroesophageal Reflux (Phase 2)

Stroke (Phase 1)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7